{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:30:46Z","timestamp":1786667446241,"version":"build-2736575974"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82401552"],"award-info":[{"award-number":["No.82401552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No.ZR2024QH590"],"award-info":[{"award-number":["No.ZR2024QH590"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05081-7","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:23:06Z","timestamp":1781011386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human stem cell models in cerebral cavernous malformations"],"prefix":"10.1186","volume":"17","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"5081_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1474-4422(07)70053-4","volume":"6","author":"P Labauge","year":"2007","unstructured":"Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6:237\u201344. https:\/\/doi.org\/10.1016\/S1474-4422(07)70053-4.","journal-title":"Lancet Neurol"},{"key":"5081_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3171\/2023.6.JNS222878","volume":"140","author":"W Ibn Essayed","year":"2024","unstructured":"Ibn Essayed W, Bernstock JD, Chen JA, Kappel AD, Ng PR, Du R. Cavernous venous malformations in and around the central nervous system. Part 1: Dural and extradural. J Neurosurg. 2024;140:735\u201345. https:\/\/doi.org\/10.3171\/2023.6.JNS222878.","journal-title":"J Neurosurg"},{"key":"5081_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/jmg.2006.041079","volume":"43","author":"N Revencu","year":"2006","unstructured":"Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet. 2006;43:716\u201321. https:\/\/doi.org\/10.1136\/jmg.2006.041079.","journal-title":"J Med Genet"},{"key":"5081_CR4","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","volume":"39","author":"R Al-Shahi Salman","year":"2008","unstructured":"Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA. Hemorrhage From Cavernous Malformations of the Brain: Definition and Reporting Standards. Stroke. 2008;39:3222\u201330. https:\/\/doi.org\/10.1161\/STROKEAHA.108.515544.","journal-title":"Stroke"},{"key":"5081_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuros\/nyx091","volume":"80","author":"A Akers","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, Awad A, Dahlem I, Flemming K, Hart K. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. NEUROSURGERY. 2017;80:665\u201380. https:\/\/doi.org\/10.1093\/neuros\/nyx091.","journal-title":"NEUROSURGERY"},{"key":"5081_CR6","doi-asserted-by":"publisher","first-page":"e70276","DOI":"10.1111\/ene.70276","volume":"32","author":"I Bratu","year":"2025","unstructured":"Bratu I, De Clerck L, Catenoix H, Valton L, Aupy J, Nica A, et al. Cerebral Cavernous Malformations and Focal Drug-Resistant Epilepsy: Behind a Quid Pro Quo of Lesion and Epileptogenic Networks. Euro J Neurol. 2025;32:e70276. https:\/\/doi.org\/10.1111\/ene.70276.","journal-title":"Euro J Neurol"},{"key":"5081_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10456-025-10011-x","volume":"28","author":"W Zheng","year":"2025","unstructured":"Zheng W, Chen L, Ma J, Zuo Y, Yu S, Li J, et al. Single-cell sequencing insights into the transcriptional landscape of cerebral cavernous malformations. Angiogenesis. 2025;28:53. https:\/\/doi.org\/10.1007\/s10456-025-10011-x.","journal-title":"Angiogenesis"},{"key":"5081_CR8","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awab117","volume":"144","author":"T Hong","year":"2021","unstructured":"Hong T, Xiao X, Ren J, Cui B, Zong Y, Zou J, et al. Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain. 2021;144:2648\u201358. https:\/\/doi.org\/10.1093\/brain\/awab117.","journal-title":"Brain"},{"key":"5081_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","volume":"76","author":"F Bergametti","year":"2005","unstructured":"Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations. Am J Hum Genet. 2005;76:42\u201351. https:\/\/doi.org\/10.1086\/426952.","journal-title":"Am J Hum Genet"},{"key":"5081_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/13815","volume":"23","author":"SL Couteulx","year":"1999","unstructured":"Couteulx SL, Jung HH, Labauge P, Houtteville J-P, Lescoat C, Cecillon M, et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet. 1999;23:189\u201393. https:\/\/doi.org\/10.1038\/13815.","journal-title":"Nat Genet"},{"key":"5081_CR11","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/380314","volume":"73","author":"CL Liquori","year":"2003","unstructured":"Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous Malformations. Am J Hum Genet. 2003;73:1459\u201364. https:\/\/doi.org\/10.1086\/380314.","journal-title":"Am J Hum Genet"},{"key":"5081_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/svn-2018-000195","volume":"4","author":"K Wang","year":"2019","unstructured":"Wang K, Zhou HJ, Wang M. CCM3 and cerebral cavernous malformation disease. Stroke Vasc Neurol. 2019;4:67\u201370. https:\/\/doi.org\/10.1136\/svn-2018-000195.","journal-title":"Stroke Vasc Neurol"},{"key":"5081_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1161\/STROKEAHA.124.049935","volume":"56","author":"H Xu","year":"2025","unstructured":"Xu H, Yang Y, Zhou Q, Huo R, Zhao S, Sun Y, et al. Map3k3 I441M Knock-In Mouse Model of Cerebral Cavernous Malformations. Stroke. 2025;56:1010\u201325. https:\/\/doi.org\/10.1161\/STROKEAHA.124.049935.","journal-title":"Stroke"},{"key":"5081_CR14","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1161\/STROKEAHA.114.005132","volume":"45","author":"S Eisa-Beygi","year":"2014","unstructured":"Eisa-Beygi S, Wen X-Y, Macdonald RL. A Call for Rigorous Study of Statins in Resolution of Cerebral Cavernous Malformation Pathology. Stroke. 2014;45:1859\u201361. https:\/\/doi.org\/10.1161\/STROKEAHA.114.005132.","journal-title":"Stroke"},{"key":"5081_CR15","doi-asserted-by":"publisher","first-page":"102421","DOI":"10.1016\/j.scr.2021.102421","volume":"54","author":"AA Beltran","year":"2021","unstructured":"Beltran AA, Molina SG, Marquez A, Munoz LJ, Olivares JF, Beltran AS. Generation of an induced pluripotent stem cell line (UNCCi002-A) from a healthy donor using a non-integration system to study Cerebral Cavernous Malformation (CCM). Stem Cell Res. 2021;54:102421. https:\/\/doi.org\/10.1016\/j.scr.2021.102421.","journal-title":"Stem Cell Res"},{"key":"5081_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007;131:861\u201372. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019.","journal-title":"Cell"},{"key":"5081_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.molmed.2013.02.004","volume":"19","author":"A Fischer","year":"2013","unstructured":"Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med. 2013;19:302\u20138. https:\/\/doi.org\/10.1016\/j.molmed.2013.02.004.","journal-title":"Trends Mol Med"},{"key":"5081_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18:919\u201330. https:\/\/doi.org\/10.1093\/hmg\/ddn430.","journal-title":"Hum Mol Genet"},{"key":"5081_CR19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1742-4658.2009.07535.x","volume":"277","author":"F Riant","year":"2010","unstructured":"Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010;277:1070\u20135. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07535.x.","journal-title":"FEBS J"},{"key":"5081_CR20","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1161\/ATVBAHA.120.314586","volume":"40","author":"K Wang","year":"2020","unstructured":"Wang K, Zhang H, He Y, Jiang Q, Tanaka Y, Park I-H, et al. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations. ATVB. 2020;40:2171\u201386. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314586.","journal-title":"ATVB"},{"key":"5081_CR21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1242\/dev.093526","volume":"141","author":"A Louvi","year":"2014","unstructured":"Louvi A, Nishimura S, G\u00fcnel M. Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration. Development. 2014;141:1404\u201315. https:\/\/doi.org\/10.1242\/dev.093526.","journal-title":"Development"},{"key":"5081_CR22","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1038\/s41467-019-10707-x","volume":"10","author":"M Malinverno","year":"2019","unstructured":"Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M, et al. Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat Commun. 2019;10:2761. https:\/\/doi.org\/10.1038\/s41467-019-10707-x.","journal-title":"Nat Commun"},{"key":"5081_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2021.04.005","volume":"108","author":"J Weng","year":"2021","unstructured":"Weng J, Yang Y, Song D, Huo R, Li H, Chen Y, et al. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. Am J Hum Genet. 2021;108:942\u201350. https:\/\/doi.org\/10.1016\/j.ajhg.2021.04.005.","journal-title":"Am J Hum Genet"},{"key":"5081_CR24","doi-asserted-by":"publisher","first-page":"946324","DOI":"10.3389\/fneur.2022.946324","volume":"13","author":"R Huo","year":"2022","unstructured":"Huo R, Wang J, Sun Y-F, Weng J-C, Li H, Jiao Y-M, et al. Simplex cerebral cavernous malformations with MAP3K3 mutation have distinct clinical characteristics. Front Neurol. 2022;13:946324. https:\/\/doi.org\/10.3389\/fneur.2022.946324.","journal-title":"Front Neurol"},{"key":"5081_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre M, Miyagishima D, Bielle F, Chapon F, Sierant M, Venot Q, et al. Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations. N Engl J Med. 2021;385:996\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa2100440.","journal-title":"N Engl J Med"},{"key":"5081_CR26","doi-asserted-by":"publisher","unstructured":"Snellings DA, Girard R, Lightle R, Srinath A, Romanos S, Li Y et al. Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. 2022;1\u201315. https:\/\/doi.org\/10.1038\/s44161-022-00035-7.","DOI":"10.1038\/s44161-022-00035-7"},{"key":"5081_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10456-023-09866-9","volume":"26","author":"R Huo","year":"2023","unstructured":"Huo R, Yang Y, Sun Y, Zhou Q, Zhao S, Mo Z, et al. Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation. Angiogenesis. 2023;26:295\u2013312. https:\/\/doi.org\/10.1007\/s10456-023-09866-9.","journal-title":"Angiogenesis"},{"key":"5081_CR28","doi-asserted-by":"publisher","first-page":"101528","DOI":"10.1016\/j.tice.2021.101528","volume":"72","author":"L Sati","year":"2021","unstructured":"Sati L, Soygur B, Goksu E, Bassorgun CI, McGrath J. CTCFL expression is associated with cerebral vascular abnormalities. Tissue Cell. 2021;72:101528. https:\/\/doi.org\/10.1016\/j.tice.2021.101528.","journal-title":"Tissue Cell"},{"key":"5081_CR29","doi-asserted-by":"publisher","first-page":"e151382","DOI":"10.1172\/JCI151382","volume":"132","author":"Z Fang","year":"2022","unstructured":"Fang Z, Sun X, Wang X, Ma J, Palaia T, Rana U, et al. NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation\u2013mediated CCM1\/2 expression. J Clin Invest. 2022;132:e151382. https:\/\/doi.org\/10.1172\/JCI151382.","journal-title":"J Clin Invest"},{"key":"5081_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.200705175","volume":"179","author":"A Glading","year":"2007","unstructured":"Glading A, Han J, Stockton RA, Ginsberg MH. KRIT-1\/CCM1 is a Rap1 effector that regulates endothelial cell\u2013cell junctions. J Cell Biol. 2007;179:247\u201354. https:\/\/doi.org\/10.1083\/jcb.200705175.","journal-title":"J Cell Biol"},{"key":"5081_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2017.11.014","volume":"115","author":"C Antognelli","year":"2018","unstructured":"Antognelli C, Trapani E, Delle Monache S, Perrelli A, Daga M, Pizzimenti S, et al. KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease. Free Radic Biol Med. 2018;115:202\u201318. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.11.014.","journal-title":"Free Radic Biol Med"},{"key":"5081_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2013.11.020","volume":"68","author":"L Goitre","year":"2014","unstructured":"Goitre L, De Luca E, Braggion S, Trapani E, Guglielmotto M, Biasi F, et al. KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun. Free Radic Biol Med. 2014;68:134\u201347. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.11.020.","journal-title":"Free Radic Biol Med"},{"key":"5081_CR33","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/cells14191510","volume":"14","author":"J Rodemerk","year":"2025","unstructured":"Rodemerk J, Engel A, Horstmann JLH, Rauschenbach L, Darkwah Oppong M, Santos AN, et al. Inflammation in Cerebral Cavernous Malformations: Differences Between Malformation Related Epilepsy vs. Symptomatic Hemorrhage Cells. 2025;14:1510. https:\/\/doi.org\/10.3390\/cells14191510.","journal-title":"Symptomatic Hemorrhage Cells"},{"key":"5081_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang AT, Wong W-Y, Bamezai S, Goddard LM, Shenkar R, et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3\u2013KLF2\/4 signalling. Nature. 2016;532:122\u20136. https:\/\/doi.org\/10.1038\/nature17178.","journal-title":"Nature"},{"key":"5081_CR35","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1182\/blood.2021013934","volume":"139","author":"Y Yang","year":"2022","unstructured":"Yang Y, Mumau M, Tober J, Zhu Q, Bennett L, Hong C, et al. Endothelial MEKK3-KLF2\/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis. Blood. 2022;139:2942\u201357. https:\/\/doi.org\/10.1182\/blood.2021013934.","journal-title":"Blood"},{"key":"5081_CR36","doi-asserted-by":"publisher","unstructured":"Min W, Qin L, Zhang H, L\u00f3pez-Gir\u00e1ldez F, Jiang N, Kim Y et al. mTORC1 signaling in brain endothelial progenitors contributes to CCM pathogenesis. Circ Res. 2024;135. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.324015.","DOI":"10.1161\/CIRCRESAHA.123.324015"},{"key":"5081_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, Snellings DA, Yourong S, Su, Hong CC, Castro M, Tang AT, et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021;594:271\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03562-8.","journal-title":"Nature"},{"key":"5081_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","volume":"32","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Rawnsley DR, Goddard LM, Pan W, Cao X-J, Jakus Z, et al. The Cerebral Cavernous Malformation Pathway Controls Cardiac Development via Regulation of Endocardial MEKK3 Signaling and KLF Expression. Dev Cell. 2015;32:168\u201380. https:\/\/doi.org\/10.1016\/j.devcel.2014.12.009.","journal-title":"Dev Cell"},{"key":"5081_CR39","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday G, Rudini N, Maddaluno L, Bl\u00e9con A, Arnould M, Gaudric A, et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med. 2011;208:1835\u201347. https:\/\/doi.org\/10.1084\/jem.20110571.","journal-title":"J Exp Med"},{"key":"5081_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15252\/emmm.201505433","volume":"8","author":"R Cuttano","year":"2016","unstructured":"Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E, et al. KLF 4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med. 2016;8:6\u201324. https:\/\/doi.org\/10.15252\/emmm.201505433.","journal-title":"EMBO Mol Med"},{"key":"5081_CR41","doi-asserted-by":"publisher","first-page":"119488","DOI":"10.1016\/j.bbamcr.2023.119488","volume":"1870","author":"C Qi","year":"2023","unstructured":"Qi C, Bujaroski RS, Baell J, Zheng X. Kinases in cerebral cavernous malformations: pathogenesis and therapeutic targets. Biochim Biophys Acta (BBA) -. Mol Cell Res. 2023;1870:119488. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119488.","journal-title":"Mol Cell Res"},{"key":"5081_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/neuros\/nyx078","volume":"81","author":"S Takada","year":"2017","unstructured":"Takada S, Hojo M, Tanigaki K, Miyamoto S. Contribution of Endothelial-to-Mesenchymal Transition to the Pathogenesis of Human Cerebral and Orbital Cavernous Malformations. NEUROSURGERY. 2017;81:176\u201383. https:\/\/doi.org\/10.1093\/neuros\/nyx078.","journal-title":"NEUROSURGERY"},{"key":"5081_CR43","doi-asserted-by":"publisher","first-page":"e160372","DOI":"10.1172\/jci.insight.160372","volume":"8","author":"X Yang","year":"2023","unstructured":"Yang X, Wu S-T, Gao R, Wang R, Wang Y, Dong Z, et al. Release of STK24\/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation. JCI Insight. 2023;8:e160372. https:\/\/doi.org\/10.1172\/jci.insight.160372.","journal-title":"JCI Insight"},{"key":"5081_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.devcel.2006.09.006","volume":"11","author":"JS Lee","year":"2006","unstructured":"Lee JS, Yu Q, Shin JT, Sebzda E, Bertozzi C, Chen M, et al. Klf2 is an essential regulator of vascular hemodynamic forces In vivo. Dev Cell. 2006;11:845\u201357. https:\/\/doi.org\/10.1016\/j.devcel.2006.09.006.","journal-title":"Dev Cell"},{"key":"5081_CR45","doi-asserted-by":"publisher","unstructured":"Vermot J, Forouhar AS, Liebling M, Wu D, Plummer D, Gharib M et al. Reversing blood flows act through klf2a to ensure normal valvulogenesis in the developing heart. PLoS Biol. 2009;7:e1000246. https:\/\/doi.org\/10.1371\/journal.pbio.1000246.","DOI":"10.1371\/journal.pbio.1000246"},{"key":"5081_CR46","doi-asserted-by":"publisher","first-page":"e024303","DOI":"10.1161\/JAHA.121.024303","volume":"12","author":"DR Sweet","year":"2023","unstructured":"Sweet DR, Padmanabhan R, Liao X, Dashora HR, Tang X, Nayak L, et al. Kr\u00fcppel-like factors orchestrate endothelial gene expression through redundant and non-redundant enhancer networks. J Am Heart Assoc. 2023;12:e024303. https:\/\/doi.org\/10.1161\/JAHA.121.024303.","journal-title":"J Am Heart Assoc"},{"key":"5081_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.devcel.2017.09.023","volume":"43","author":"LM Goddard","year":"2017","unstructured":"Goddard LM, Duchemin A-L, Ramalingan H, Wu B, Chen M, Bamezai S, et al. Hemodynamic forces sculpt developing heart valves through a KLF2-WNT9B paracrine signaling axis. Dev Cell. 2017;43:274\u2013e2895. https:\/\/doi.org\/10.1016\/j.devcel.2017.09.023.","journal-title":"Dev Cell"},{"key":"5081_CR48","doi-asserted-by":"publisher","unstructured":"Lai CC, Nelsen B, Frias-Anaya E, Gallego-Gutierrez H, Orecchioni M, Herrera V, Ortiz E, Sun H, Mesarwi OA, Ley K, Gongol B, Lopez-Ramirez MA. Neuroinflammation plays a critical role in cerebral cavernous malformation disease. Circ Res. 2022;131(11):909\u201325. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321129","DOI":"10.1161\/CIRCRESAHA.122.321129"},{"key":"5081_CR49","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/ATVBAHA.123.320367","volume":"44","author":"E Frias-Anaya","year":"2024","unstructured":"Frias-Anaya E, Gallego-Gutierrez H, Gongol B, Weinsheimer S, Lai CC, Orecchioni M, et al. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. ATVB. 2024;44:1246\u201364. https:\/\/doi.org\/10.1161\/ATVBAHA.123.320367.","journal-title":"ATVB"},{"key":"5081_CR50","doi-asserted-by":"publisher","first-page":"8622","DOI":"10.3390\/ijms26178622","volume":"26","author":"H Sadegh","year":"2025","unstructured":"Sadegh H, Choi JP. The Emerging Role of the Gut Microbiome in Cerebral Cavernous Malformation: A New Novel Therapeutic Strategy? IJMS. 2025;26:8622. https:\/\/doi.org\/10.3390\/ijms26178622.","journal-title":"IJMS"},{"key":"5081_CR51","doi-asserted-by":"publisher","first-page":"e9155","DOI":"10.15252\/emmm.201809155","volume":"10","author":"C Otten","year":"2018","unstructured":"Otten C, Knox J, Boulday G, Eymery M, Haniszewski M, Neuenschwander M, et al. Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Mol Med. 2018;10:e9155. https:\/\/doi.org\/10.15252\/emmm.201809155.","journal-title":"EMBO Mol Med"},{"key":"5081_CR52","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1073\/pnas.1501352112","volume":"112","author":"L Bravi","year":"2015","unstructured":"Bravi L, Rudini N, Cuttano R, Giampietro C, Maddaluno L, Ferrarini L, et al. Sulindac metabolites decrease cerebrovascular malformations in CCM3 -knockout mice. Proc Natl Acad Sci USA. 2015;112:8421\u20136. https:\/\/doi.org\/10.1073\/pnas.1501352112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5081_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492\u20136. https:\/\/doi.org\/10.1038\/nature12207.","journal-title":"Nature"},{"key":"5081_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm.1911","volume":"15","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med. 2009;15:177\u201384. https:\/\/doi.org\/10.1038\/nm.1911.","journal-title":"Nat Med"},{"key":"5081_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00018-025-05854-y","volume":"82","author":"S Ahalya","year":"2025","unstructured":"Ahalya S, Karthika CL, Sreelakshmi BJ, Kalpana SR, Sumi S. Altered venous flow drives endothelial to mesenchymal transition in varicose veins by suppressing PIEZO1-KLF2 signaling. Cell Mol Life Sci. 2025;82:345\u201363. https:\/\/doi.org\/10.1007\/s00018-025-05854-y.","journal-title":"Cell Mol Life Sci"},{"key":"5081_CR56","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/STROKEAHA.122.041507","volume":"54","author":"W Zhang","year":"2023","unstructured":"Zhang W, Pu H, Hu X, Shi Y, Leak RK, Anne Stetler R, et al. Poststroke Intravenous Transplantation of Human Mesenchymal Stem Cells Improves Brain Repair Dynamics and Functional Outcomes in Aged Mice. Stroke. 2023;54:1088\u201398. https:\/\/doi.org\/10.1161\/STROKEAHA.122.041507.","journal-title":"Stroke"},{"key":"5081_CR57","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4103\/1673-5374.205085","volume":"12","author":"J P\u00edas-Peleteiro","year":"2017","unstructured":"P\u00edas-Peleteiro J, Campos F, Castillo J, Sobrino T. Endothelial progenitor cells as a therapeutic option in intracerebral hemorrhage. Neural Regen Res. 2017;12:558. https:\/\/doi.org\/10.4103\/1673-5374.205085.","journal-title":"Neural Regen Res"},{"key":"5081_CR58","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.3390\/ijms24043993","volume":"24","author":"RA Pilz","year":"2023","unstructured":"Pilz RA, Skowronek D, Mellinger L, Bekeschus S, Felbor U, Rath M. Endothelial Differentiation of CCM1 Knockout iPSCs Triggers the Establishment of a Specific Gene Expression Signature. IJMS. 2023;24:3993. https:\/\/doi.org\/10.3390\/ijms24043993.","journal-title":"IJMS"},{"key":"5081_CR59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jacbts.2023.04.008","volume":"9","author":"A Lin","year":"2024","unstructured":"Lin A, Brittan M, Baker AH, Dimmeler S, Fisher EA, Sluimer JC, et al. Clonal Expansion in Cardiovascular Pathology. JACC: Basic Translational Sci. 2024;9:120\u201344. https:\/\/doi.org\/10.1016\/j.jacbts.2023.04.008.","journal-title":"JACC: Basic Translational Sci"},{"key":"5081_CR60","doi-asserted-by":"publisher","first-page":"953048","DOI":"10.3389\/fmolb.2022.953048","volume":"9","author":"RA Pilz","year":"2022","unstructured":"Pilz RA, Skowronek D, Hamed M, Weise A, Mangold E, Radbruch A, et al. Using CRISPR\/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel CCM1 transcription start site deletion. Front Mol Biosci. 2022;9:953048. https:\/\/doi.org\/10.3389\/fmolb.2022.953048.","journal-title":"Front Mol Biosci"},{"key":"5081_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/crispr.2024.0079","volume":"8","author":"G Guo","year":"2025","unstructured":"Guo G, Moser M, Chifamba L, Julian D, Teierle S, Rajappa P, et al. CRISPR-Cas9-mediated correction of TSC2 pathogenic variants in iPSCs from patients with tuberous sclerosis complex type 2. CRISPR J. 2025;8:60\u201370. https:\/\/doi.org\/10.1089\/crispr.2024.0079.","journal-title":"CRISPR J"},{"key":"5081_CR62","doi-asserted-by":"publisher","first-page":"e00755","DOI":"10.1002\/mgg3.755","volume":"7","author":"S Spiegler","year":"2019","unstructured":"Spiegler S, Rath M, Much CD, Sendtner BS, Felbor U. Precise CCM1 gene correction and inactivation in patient-derived endothelial cells: modeling knudson\u2019s two-hit hypothesis in vitro. Molec Gen Gen Med. 2019;7:e00755. https:\/\/doi.org\/10.1002\/mgg3.755.","journal-title":"Molec Gen Gen Med"},{"key":"5081_CR63","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.stem.2016.08.019","volume":"20","author":"M Gu","year":"2017","unstructured":"Gu M, Shao N-Y, Sa S, Li D, Termglinchan V, Ameen M, et al. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. Cell Stem Cell. 2017;20:490\u2013e5045. https:\/\/doi.org\/10.1016\/j.stem.2016.08.019.","journal-title":"Cell Stem Cell"},{"key":"5081_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.stem.2024.10.015","volume":"32","author":"Z Pan","year":"2025","unstructured":"Pan Z, Yao Q, Kong W, Ma X, Tian L, Zhao Y, et al. Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery. Cell Stem Cell. 2025;32:227\u2013e2459. https:\/\/doi.org\/10.1016\/j.stem.2024.10.015.","journal-title":"Cell Stem Cell"},{"key":"5081_CR65","doi-asserted-by":"publisher","first-page":"e3002141","DOI":"10.1371\/journal.pbio.3002141","volume":"21","author":"B Ye","year":"2023","unstructured":"Ye B. Approaches to vascularizing human brain organoids. PLOS Biol. 2023;21:e3002141. https:\/\/doi.org\/10.1371\/journal.pbio.3002141.","journal-title":"PLOS Biol"},{"key":"5081_CR66","doi-asserted-by":"publisher","first-page":"33140","DOI":"10.34172\/bi.33140","volume":"15","author":"A Nakhlband","year":"2025","unstructured":"Nakhlband A. Organoid-engineered neurovascular units for drug discovery and neurodegeneration research. BioImpacts. 2025;15:33140. https:\/\/doi.org\/10.34172\/bi.33140.","journal-title":"BioImpacts"},{"key":"5081_CR67","doi-asserted-by":"publisher","first-page":"e76707","DOI":"10.7554\/eLife.76707","volume":"11","author":"X-Y Sun","year":"2022","unstructured":"Sun X-Y, Ju X-C, Li Y, Zeng P-M, Wu J, Zhou Y-Y, et al. Generation of vascularized brain organoids to study neurovascular interactions. eLife. 2022;11:e76707. https:\/\/doi.org\/10.7554\/eLife.76707.","journal-title":"eLife"},{"key":"5081_CR68","doi-asserted-by":"publisher","first-page":"637048","DOI":"10.3389\/fbioe.2021.637048","volume":"9","author":"X Zhao","year":"2021","unstructured":"Zhao X, Xu Z, Xiao L, Shi T, Xiao H, Wang Y, et al. Review on the vascularization of organoids and organoids-on-a-chip. Front Bioeng Biotechnol. 2021;9:637048. https:\/\/doi.org\/10.3389\/fbioe.2021.637048.","journal-title":"Front Bioeng Biotechnol"},{"key":"5081_CR69","doi-asserted-by":"publisher","first-page":"e70161","DOI":"10.1111\/cpr.70161","volume":"59","author":"Y Song","year":"2026","unstructured":"Song Y, Jo H, Jeong S, Kim I, Lee SS. Vascularised brain organoids: engineering strategies and neurobiological applications. Cell Prolif. 2026;59:e70161. https:\/\/doi.org\/10.1111\/cpr.70161.","journal-title":"Cell Prolif"},{"key":"5081_CR70","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/s41596-019-0213-z","volume":"14","author":"RA Wimmer","year":"2019","unstructured":"Wimmer RA, Leopoldi A, Aichinger M, Kerjaschki D, Penninger JM. Generation of blood vessel organoids from human pluripotent stem cells. Nat Protoc. 2019;14:3082\u2013100. https:\/\/doi.org\/10.1038\/s41596-019-0213-z.","journal-title":"Nat Protoc"},{"key":"5081_CR71","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","volume":"565","author":"RA Wimmer","year":"2019","unstructured":"Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565:505\u201310. https:\/\/doi.org\/10.1038\/s41586-018-0858-8.","journal-title":"Nature"},{"key":"5081_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10456-025-09985-5","volume":"28","author":"D Skowronek","year":"2025","unstructured":"Skowronek D, Pilz RA, Saenko VV, Mellinger L, Singer D, Ribback S, et al. High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins. Angiogenesis. 2025;28:32. https:\/\/doi.org\/10.1007\/s10456-025-09985-5.","journal-title":"Angiogenesis"},{"key":"5081_CR73","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41467-024-45710-4","volume":"15","author":"C Quintard","year":"2024","unstructured":"Quintard C, Tubbs E, Jonsson G, Jiao J, Wang J, Werschler N, et al. A microfluidic platform integrating functional vascularized organoids-on-chip. Nat Commun. 2024;15:1452. https:\/\/doi.org\/10.1038\/s41467-024-45710-4.","journal-title":"Nat Commun"},{"key":"5081_CR74","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","volume":"31","author":"L Dao","year":"2024","unstructured":"Dao L, You Z, Lu L, Xu T, Sarkar AK, Zhu H, et al. Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell. 2024;31:818\u2013e83311. https:\/\/doi.org\/10.1016\/j.stem.2024.04.019.","journal-title":"Cell Stem Cell"},{"key":"5081_CR75","doi-asserted-by":"publisher","first-page":"115576","DOI":"10.1016\/j.celrep.2025.115576","volume":"44","author":"M Arce","year":"2025","unstructured":"Arce M, Erzar I, Yang F, Senthilkumar N, Onyeogaziri FC, Ronchi D, et al. KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation. Cell Rep. 2025;44:115576. https:\/\/doi.org\/10.1016\/j.celrep.2025.115576.","journal-title":"Cell Rep"},{"key":"5081_CR76","doi-asserted-by":"publisher","first-page":"104914","DOI":"10.1016\/j.ebiom.2023.104914","volume":"99","author":"F Lazzaroni","year":"2024","unstructured":"Lazzaroni F, Meessen JMTA, Sun Y, Lanfranconi S, Scola E, D\u2019Alessandris QG, et al. Circulating biomarkers in familial cerebral cavernous malformation. eBioMedicine. 2024;99:104914. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104914.","journal-title":"eBioMedicine"},{"key":"5081_CR77","doi-asserted-by":"publisher","first-page":"121729","DOI":"10.1016\/j.biomaterials.2022.121729","volume":"288","author":"K Soon","year":"2022","unstructured":"Soon K, Li M, Wu R, Zhou A, Khosraviani N, Turner WD, et al. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks. Biomaterials. 2022;288:121729. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121729.","journal-title":"Biomaterials"},{"key":"5081_CR78","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00018-022-04355-6","volume":"79","author":"M Rath","year":"2022","unstructured":"Rath M, Schwefel K, Malinverno M, Skowronek D, Leopoldi A, Pilz RA, et al. Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells. Cell Mol Life Sci. 2022;79:340. https:\/\/doi.org\/10.1007\/s00018-022-04355-6.","journal-title":"Cell Mol Life Sci"},{"key":"5081_CR79","doi-asserted-by":"publisher","first-page":"102015","DOI":"10.1016\/j.scr.2020.102015","volume":"49","author":"SG Molina","year":"2020","unstructured":"Molina SG, Beltran AA, Beltran AS. Generation of an integration-free induced pluripotent stem cell line (UNC001-A) from blood of a healthy individual. Stem Cell Res. 2020;49:102015. https:\/\/doi.org\/10.1016\/j.scr.2020.102015.","journal-title":"Stem Cell Res"},{"key":"5081_CR80","doi-asserted-by":"publisher","first-page":"eadq2616","DOI":"10.1126\/sciadv.adq2616","volume":"11","author":"M Trevisani","year":"2025","unstructured":"Trevisani M, Berselli A, Alberini G, Centonze E, Vercellino S, Cartocci V, et al. A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro. Sci Adv. 2025;11:eadq2616. https:\/\/doi.org\/10.1126\/sciadv.adq2616.","journal-title":"Sci Adv"},{"key":"5081_CR81","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1515\/medgen-2021-2091","volume":"33","author":"D Skowronek","year":"2021","unstructured":"Skowronek D, Pilz RA, Schwefel K, Much CD, Felbor U, Rath M. Bringing CCM into a dish: cell culture models for cerebral cavernous malformations. Med Genet. 2021;33:251\u20139. https:\/\/doi.org\/10.1515\/medgen-2021-2091.","journal-title":"Med Genet"},{"key":"5081_CR82","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1002\/ctm2.99","volume":"10","author":"LD Shoemaker","year":"2020","unstructured":"Shoemaker LD, McCormick AK, Allen BM, Chang SD. Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations. Clin Transl Med. 2020;10:e99. https:\/\/doi.org\/10.1002\/ctm2.99.","journal-title":"Clin Transl Med"},{"key":"5081_CR83","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1039\/D2LC01109C","volume":"23","author":"SY Tan","year":"2023","unstructured":"Tan SY, Feng X, Cheng LKW, Wu AR. Vascularized human brain organoid on-chip. Lab Chip. 2023;23:2693\u2013709. https:\/\/doi.org\/10.1039\/D2LC01109C.","journal-title":"Lab Chip"},{"key":"5081_CR84","doi-asserted-by":"publisher","first-page":"591450","DOI":"10.3389\/fphys.2020.591450","volume":"11","author":"E Helle","year":"2020","unstructured":"Helle E, Ampuja M, Antola L, Kivel\u00e4 R. Flow-induced transcriptomic remodeling of endothelial cells derived from human induced pluripotent stem cells. Front Physiol. 2020;11:591450. https:\/\/doi.org\/10.3389\/fphys.2020.591450.","journal-title":"Front Physiol"},{"key":"5081_CR85","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","volume":"21","author":"DE Wagner","year":"2020","unstructured":"Wagner DE, Klein AM. Lineage tracing meets single-cell omics: opportunities and challenges. Nat Rev Genet. 2020;21:410\u201327. https:\/\/doi.org\/10.1038\/s41576-020-0223-2.","journal-title":"Nat Rev Genet"},{"key":"5081_CR86","doi-asserted-by":"publisher","first-page":"e20200858","DOI":"10.1084\/jem.20200858","volume":"217","author":"WA Muller","year":"2020","unstructured":"Muller WA. Beyond genes and transcription factors: a potential mechanism for the pathogenesis of cerebral cavernous malformations. J Exp Med. 2020;217:e20200858. https:\/\/doi.org\/10.1084\/jem.20200858.","journal-title":"J Exp Med"},{"key":"5081_CR87","doi-asserted-by":"publisher","first-page":"e200121","DOI":"10.1212\/NXG.0000000000200121","volume":"10","author":"C Ayata","year":"2024","unstructured":"Ayata C, Kim H, Morrison L, Liao JK, Gutierrez J, Lopez-Toledano M, et al. Role of rho-associated kinase in the pathophysiology of cerebral cavernous malformations. Neurol Genet. 2024;10:e200121. https:\/\/doi.org\/10.1212\/NXG.0000000000200121.","journal-title":"Neurol Genet"},{"key":"5081_CR88","doi-asserted-by":"publisher","first-page":"200263","DOI":"10.1098\/rsob.200263","volume":"10","author":"VL Su","year":"2020","unstructured":"Su VL, Calderwood DA. Signalling through cerebral cavernous malformation protein networks. Open Biol. 2020;10:200263. https:\/\/doi.org\/10.1098\/rsob.200263.","journal-title":"Open Biol"},{"key":"5081_CR89","doi-asserted-by":"publisher","first-page":"e70223","DOI":"10.1002\/brb3.70223","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Deng J, Sun W, Wang Z. Cerebral cavernous malformation: from genetics to pharmacotherapy. Brain Behav. 2025;15:e70223. https:\/\/doi.org\/10.1002\/brb3.70223.","journal-title":"Brain Behav"},{"key":"5081_CR90","doi-asserted-by":"publisher","first-page":"e61413","DOI":"10.7554\/eLife.61413","volume":"9","author":"F Orsenigo","year":"2020","unstructured":"Orsenigo F, Conze LL, Jauhiainen S, Corada M, Lazzaroni F, Malinverno M, et al. Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution. eLife. 2020;9:e61413. https:\/\/doi.org\/10.7554\/eLife.61413.","journal-title":"eLife"},{"key":"5081_CR91","doi-asserted-by":"publisher","unstructured":"Fisher DG, Sharifi KA, Ulutas EZ, Kumar JS, Kalani MYS, Miller GW et al. Understanding lesion progression in a chronic model of cerebral cavernous malformations through combined MRI and histology. Neuroscience; 2022. https:\/\/doi.org\/10.1101\/2022.11.15.516639.","DOI":"10.1101\/2022.11.15.516639"},{"key":"5081_CR92","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/RLI.0000000000000043","volume":"49","author":"H Tan","year":"2014","unstructured":"Tan H, Liu T, Wu Y, Thacker J, Shenkar R, Mikati AG, et al. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014;49:498\u2013504. https:\/\/doi.org\/10.1097\/RLI.0000000000000043.","journal-title":"Invest Radiol"},{"key":"5081_CR93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/jmedgenet-2019-106182","volume":"57","author":"M Rath","year":"2020","unstructured":"Rath M, Pagenstecher A, Hoischen A, Felbor U. Postzygotic mosaicism in cerebral cavernous malformation. J Med Genet. 2020;57:212\u20136. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106182.","journal-title":"J Med Genet"},{"key":"5081_CR94","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1038\/s41598-022-16896-8","volume":"12","author":"BF Vahsen","year":"2022","unstructured":"Vahsen BF, Gray E, Candalija A, Cramb KML, Scaber J, Dafinca R, et al. Human iPSC co-culture model to investigate the interaction between microglia and motor neurons. Sci Rep. 2022;12:12606. https:\/\/doi.org\/10.1038\/s41598-022-16896-8.","journal-title":"Sci Rep"},{"key":"5081_CR95","doi-asserted-by":"publisher","first-page":"e57920","DOI":"10.7554\/eLife.57920","volume":"9","author":"L Alonso-Herranz","year":"2020","unstructured":"Alonso-Herranz L, Sah\u00fan-Espa\u00f1ol \u00c1, Paredes A, Gonzalo P, Gkontra P, N\u00fa\u00f1ez V, et al. Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP\/TGF\u03b21 after myocardial infarction. eLife. 2020;9:e57920. https:\/\/doi.org\/10.7554\/eLife.57920.","journal-title":"eLife"},{"key":"5081_CR96","doi-asserted-by":"publisher","first-page":"e0232356","DOI":"10.1371\/journal.pone.0232356","volume":"15","author":"Y Yoshimatsu","year":"2020","unstructured":"Yoshimatsu Y, Kimuro S, Pauty J, Takagaki K, Nomiyama S, Inagawa A, et al. TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of activin signals. Takakura N, editor. PLoS ONE. 2020;15:e0232356. https:\/\/doi.org\/10.1371\/journal.pone.0232356.","journal-title":"PLoS ONE"},{"key":"5081_CR97","doi-asserted-by":"publisher","unstructured":"Suzuki HI, Horie M, Mihira H, Saito A. Molecular analysis of endothelial-mesenchymal transition induced by transforming growth factor-\u03b2 signaling. J Visualized Exp. 2018;57577. https:\/\/doi.org\/10.3791\/57577.","DOI":"10.3791\/57577."},{"key":"5081_CR98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fcell.2020.00260","volume":"8","author":"J Ma","year":"2020","unstructured":"Ma J, Sanchez-Duffhues G, Goumans M-J, Ten Dijke P. TGF-\u03b2-induced endothelial to mesenchymal transition in disease and tissue engineering. Front Cell Dev Biol. 2020;8:260\u201373. https:\/\/doi.org\/10.3389\/fcell.2020.00260.","journal-title":"Front Cell Dev Biol"},{"key":"5081_CR99","doi-asserted-by":"publisher","first-page":"1800725","DOI":"10.1002\/biot.201800725","volume":"14","author":"KK Dunn","year":"2019","unstructured":"Dunn KK, Reichardt IM, Simmons AD, Jin G, Floy ME, Hoon KM, et al. Coculture of endothelial cells with human pluripotent stem cell-derived cardiac progenitors reveals a differentiation stage-specific enhancement of cardiomyocyte maturation. Biotechnol J. 2019;14:1800725. https:\/\/doi.org\/10.1002\/biot.201800725.","journal-title":"Biotechnol J"},{"key":"5081_CR100","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/ijms27020780","volume":"27","author":"L Fontanelli","year":"2026","unstructured":"Fontanelli L, Castronovo A, Ferri C, Vozzi F, Recchia FA, Borghini A. iPSC-derived endothelial cells as experimental models for predictive and personalized strategies in cardiovascular and cerebrovascular disease. Int J Mol Sci. 2026;27:780\u201398. https:\/\/doi.org\/10.3390\/ijms27020780.","journal-title":"Int J Mol Sci"},{"key":"5081_CR101","doi-asserted-by":"publisher","unstructured":"McVicar RN, Smith E, Melameka M, Bush A, Goetz G, Constantino G, et al. iPSC-derived epithelial, mesenchymal, endothelial, and immune cell Co-culture to model airway barrier integrity in lung health and disease. J Visualized Exp. 2024;67247. https:\/\/doi.org\/10.3791\/67247.","DOI":"10.3791\/67247"},{"key":"5081_CR102","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nbt.3155","volume":"33","author":"LE Dow","year":"2015","unstructured":"Dow LE, Fisher J, O\u2019Rourke KP, Muley A, Kastenhuber ER, Livshits G, et al. Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol. 2015;33:390\u20134. https:\/\/doi.org\/10.1038\/nbt.3155.","journal-title":"Nat Biotechnol"},{"key":"5081_CR103","doi-asserted-by":"publisher","first-page":"16532","DOI":"10.1038\/s41598-021-95986-5","volume":"11","author":"Y Shamshirgaran","year":"2021","unstructured":"Shamshirgaran Y, Jonebring A, Svensson A, Leefa I, Bohlooly-Y M, Firth M, et al. Rapid target validation in a Cas9-inducible hiPSC derived kidney model. Sci Rep. 2021;11:16532. https:\/\/doi.org\/10.1038\/s41598-021-95986-5.","journal-title":"Sci Rep"},{"key":"5081_CR104","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/gb-2014-15-5-r75","volume":"15","author":"SN Porter","year":"2014","unstructured":"Porter SN, Baker LC, Mittelman D, Porteus MH. Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivo. Genome Biol. 2014;15:R75. https:\/\/doi.org\/10.1186\/gb-2014-15-5-r75.","journal-title":"Genome Biol"},{"key":"5081_CR105","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1038\/s41596-018-0058-x","volume":"13","author":"B Raj","year":"2018","unstructured":"Raj B, Gagnon JA, Schier AF. Large-scale reconstruction of cell lineages using single-cell readout of transcriptomes and CRISPR\u2013Cas9 barcodes by scGESTALT. Nat Protoc. 2018;13:2685\u2013713. https:\/\/doi.org\/10.1038\/s41596-018-0058-x.","journal-title":"Nat Protoc"},{"key":"5081_CR106","doi-asserted-by":"publisher","first-page":"121575","DOI":"10.1016\/j.biomaterials.2022.121575","volume":"286","author":"H Kim","year":"2022","unstructured":"Kim H, Im I, Jeon JS, Kang E-H, Lee H-A, Jo S, et al. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials. 2022;286:121575. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121575.","journal-title":"Biomaterials"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05081-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:11:56Z","timestamp":1786666316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5081"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05081-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"278"}}